Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Only increase if lower doses plateau and you tolerate well
Abstract Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are approved for treating type 2 diabetes and obesity and are under investigation as potential treatments for substance use disorders (SUD)
They may recommend taking your next dose as scheduled, or they may have you start the titration process from the beginning with a lower dose of Wegovy
Nat Commun 15:4548 Wharton S, Calanna S, Davies M et al (2022) Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between Gastrointestinal adverse events and weight loss
US$ 21.50
US$ 26.83
US$ 25.33
US$ 27.77
US$ 27.30
US$ 22.36
US$ 20.92
